Evolus (EOLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in the TD Cowen 2nd ...

Evolus Inc . (NASDAQ:EOLS), a company specializing in aesthetic products with a market capitalization of $933 million, has recently made significant strides in expanding its product portfolio and ...

HC Wainwright reissued their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a research report report published on Friday,Benzinga reports. HC Wainwright currently has a $27.00 price ...

Evolus, Inc. EOLS shares rallied 5.5% in the last trading session to close at $15.04. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

During the last three months, 4 analysts shared their evaluations of Evolus EOLS, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings ...

The FDA has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels, two dermal fillers from Evolus, the ...